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Hippurate-Zinc layered Hydroxide Nanohybrid and its synergistic effect with 
Tamoxifen on the HepG2 cell lines. 
 
ABSTRACT 
A new simple preparation method for a hippurate intercalated zinc-layered hydroxide (ZLH) 
nanohybrid has been established, which does not need an anion-exchange procedure to 
intercalate the hippurate anion into ZLH interlayers. Methods: The hippuric acid nanohybrid 
(HAN) was prepared by direct reaction of an aqueous suspension of zinc oxide with a 
solution of hippuric acid via a one-step method. Results: The basal spacing of the nanohybrid 
was 21.3 Å, indicating that the hippurate anion was successfully intercalated into the 
interlayer space of ZLH, and arranged in a monolayer fashion with the carboxylate group 
pointing toward the ZLH inorganic interlayers. A Fourier transform infrared study confirmed 
the formation of the nanohybrid, while thermogravimetry and differential thermogravimetry 
analyses showed that the thermal stability of the nanohybrid was markedly enhanced. The 
loading of hippurate in the nanohybrid was estimated to be about 38.7% (w/w), and the 
release of hippurate from the nanohybrid was of a controlled manner, and therefore the 
resulting material was suitable for use as a controlled-release formulation. HAN has 
synergistic properties with tamoxifen toward a HepG2 cell line, with an IC 50 value of 0.35 
compared with hippurate. In the antiproliferative assay, the ratio of viable cells account for 
cells treated by the combination tamoxifen with HAN to untreated cells was sharply reduced 
from 66% to 13% after 24 and 72 hours, respectively. The release of hippuric acid anions 
from HAN occurred in a controlled manner, and the resulting material is suitable for a 
controlled-release formulation.  
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